Login to Your Account

Other News To Note

Thursday, August 9, 2012

• Cynapsus Therapeutics Inc., of Toronto, received a grant of $947,925 from the Michael J. Fox Foundation for Parkinson's Research for development of APL-130277, a reformulation of apomorphine for sublingual delivery.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription